MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with B

Beclometasone

Beclometasone 0.0025% in White soft paraffin

No stability information

Stability notes for Beclometasone 0.0025% in White soft paraffin

There are no stability notes for this medicine.

Supplier

Beclometasone 0.0025% in White soft paraffin (Drug Tariff Special Order)

Beclometasone 0.025% in White soft paraffin

No stability information

Stability notes for Beclometasone 0.025% in White soft paraffin

There are no stability notes for this medicine.

Supplier

Beclometasone 0.025% in White soft paraffin (Special Order)

Beclometasone 5mg gastro-resistant modified-release tablets

Compatible

Stability notes for Beclometasone 5mg gastro-resistant modified-release tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the product Clipper 5mg gastro-resistant modified-release tablets (Chiesi Ltd).

Supplier

Clipper 5mg gastro-resistant modified-release tablets (Chiesi Ltd)

Beclometasone 50micrograms/dose breath actuated inhaler CFC free

Unsuitable

Stability notes for Beclometasone 50micrograms/dose breath actuated inhaler CFC free

There are no stability notes for this medicine.

Supplier

Qvar 50 Autohaler (Teva UK Ltd)

Beclometasone 100micrograms/dose breath actuated inhaler CFC free

Unsuitable

Stability notes for Beclometasone 100micrograms/dose breath actuated inhaler CFC free

There are no stability notes for this medicine.

Suppliers (4) of Beclometasone 100micrograms/dose breath actuated inhaler CFC free
Qvar 100 Autohaler (CST Pharma Ltd)
Qvar 100 Autohaler (Lexon (UK) Ltd)
Qvar 100 Autohaler (Sigma Pharmaceuticals Plc)
Qvar 100 Autohaler (Teva UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.